Barcelona, 3rd March 2008.

Updated: David Underwood, Chief Executive took advantage of the DIA conference in Barcelona to announce the arrival of Quanticate as a major new force within the CRO market.

Quanticate is an integration of the strengths and capabilities of two longstanding and respected CRO's in Statwood and Oxford Pharmaceutical Sciences. After 5 years of close collaboration, the two companies announced that they have successfully completed a formal integration creating a single entity called Quanticate.

With 220 members of staff and nine offices on 3 continents, Quanticate has the resources and capabilities of a truly global player. Quanticate delivers highly scalable clinical services, on and off site data management, statistical programming & analysis, medical writing solutions, and consultancy across all services.

The company has its own world class EDC / paper solution called ClinNav™ and is well known for its flexible approach to data collection and management and its ability to integrate with its customers own technology environments.

David Underwood commented: "The launch of Quanticate is a truly exciting moment in our history and provides the ideal springboard for our continued expansion into global and full service clinical research solutions. We expect to add further capabilities over the coming months and Quanticate is a name and a company that we expect to grow rapidly in terms of its recognition as a global CRO with exceptional quality."